Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ 14-3-3 eta Monoclonal Antibody (3G12)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA547416
Description
14-3-3 eta Monoclonal Antibody for Western Blot, ICC/IF, IHC
This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse, rat and bovine orthologs. This gene contains a 7 bp repeat sequence in its 5' UTR, and changes in the number of this repeat has been associated with early-onset schizophrenia.
Specifications
14-3-3 eta | |
Monoclonal | |
1 mg/mL | |
PBS with 50% glycerol and 5mM sodium azide | |
P68509, P68510, P68511, Q04917 | |
YWHAH | |
Full length human recombinant 14-3-3 (eta) protein expressed in and purified from E.coli. | |
100 μL | |
Primary | |
Human, Mouse, Rat, Canine, Bovine, Pig | |
Antibody | |
IgG1 |
Immunohistochemistry, Western Blot, Immunocytochemistry | |
3G12 | |
Unconjugated | |
YWHAH | |
14-3-3 eta; 14-3-3 protein eta; 14-3-3 protein eta-subtype; 14-3-3e; 1433F; fb93e02; Protein AS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; wu:fb51h04; wu:fb93e02; YWHA1; YWHA114-3-3 eta; ywhag; YWHAH; zgc:63883; zgc:63883 protein | |
Mouse | |
Protein A/G | |
RUO | |
100155504, 100687866, 22629, 25576, 282126, 7533 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction